RxDoctor Payments DataLook up a doctor →

Brandy Story, NP

Nurse Practitioner · Johnson City, TNNPI 1093212516

Payments from drug & device makers

$17,765in general payments, 2019–2025

Across 984 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$2K
  • AbbVie$1K
  • Neurelis, Inc.$1K
  • Novartis$1K
  • AstraZeneca$942
  • Biogen$837
  • plus $11K from 49 others

What the payments were for

  • Consulting fees$1501%
  • Speaking & faculty fees$470%
  • Food & beverage$17,46998%
  • Education$991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.68$1,515
AbbVie(2 entities)108$1,313
Neurelis, Inc.38$1,037
Novartis55$1,031
AstraZeneca(2 entities)43$942
Biogen49$837
Lundbeck LLC47$817
Jazz Pharmaceuticals Inc.25$675
Neurocrine Biosciences, Inc.32$601
MDD US Operations, LLC43$589
Genentech USA, Inc.28$548
Lilly USA, LLC33$544
Acadia Pharmaceuticals Inc31$418
Pfizer31$412
Teva Pharmaceuticals USA, Inc.21$388
Eisai Inc.20$377
Argenx US, Inc.14$344
Impel Pharmaceuticals Inc.29$342
TG Therapeutics, Inc.13$327
CSL Behring13$308
Biohaven Pharmaceuticals, Inc.18$306
Amneal Pharmaceuticals LLC18$302
Biohaven Pharmaceutical Holding Company Ltd.21$277
Johnson & Johnson10$264
Sanofi13$248
Mallinckrodt Hospital Products Inc.10$236
Amgen11$235
SK Life Science, Inc.9$211
Avanir Pharmaceuticals, Inc.11$198
EMD Serono, Inc.15$197
Sunovion Pharmaceuticals Inc.16$182
Otsuka America Pharmaceutical, Inc.9$170
Grifols USA, LLC8$162
Kyowa Kirin, Inc.8$154
Catalyst Pharmaceuticals, Inc.7$153
Sumitomo Pharma America, Inc.11$124
Axsome Therapeutics, Inc.5$119
Bristol Myers Squibb6$114
Corium, LLC5$106
Harmony Biosciences LLC4$104
Arbor Pharmaceuticals, Inc.5$100
Takeda Pharmaceuticals U.S.A., Inc.3$72
Adamas Pharmaceuticals, Inc.3$56
Impel Pharmaceuticals LLC2$42
Alnylam Pharmaceuticals Inc.2$36
Supernus Pharmaceuticals, Inc.2$34
Aprecia Pharmaceuticals, LLC2$33
Tanabe Pharma America, Inc.2$33
Sanofi-aventis U.S. LLC1$22
Acorda Therapeutics, Inc1$22
Merz Pharmaceuticals, LLC1$21
Vanda Pharmaceuticals Inc.1$20
E.r. Squibb & Sons, L.L.C.1$18
Azurity Pharmaceuticals, Inc.1$18
Almatica Pharma LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,765 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$21,411
Medicare patients
119
Services billed
224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Emgality PenGalcanezumab-Gnlm46$49,775
Austedo XrDeutetrabenazine11$40,076
Aimovig AutoinjectorErenumab-Aooe38$36,818
Emgality SyringeGalcanezumab-Gnlm16$28,105
BotoxOnabotulinumtoxina20$26,300
Nurtec OdtRimegepant Sulfate16$18,650
VimpatLacosamide14$15,997
Lacosamide24$2,606
Gabapentin74$1,509
Carbidopa-LevodopaCarbidopa/Levodopa52$1,327
Carbamazepine11$1,167
Memantine Hcl24$1,013
Primidone50$857
Pregabalin33$815
Levetiracetam28$806

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$388$40,07611 claims
AbbVieBotox$1,313$26,30020 claims
PfizerNurtec Odt$412$18,65016 claims
UCB, Inc.Vimpat$1,515$15,99714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →